Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.50
-0.73 (-3.03%)
Apr 29, 2026, 11:46 AM EDT - Market open

Damora Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-209.84-21.44-38.35-61.62-51.75
Upgrade
Depreciation & Amortization
0.030.180.830.490.44
Upgrade
Loss (Gain) From Sale of Assets
---0.06--
Upgrade
Asset Writedown & Restructuring Costs
174.31----
Upgrade
Loss (Gain) From Sale of Investments
-0.07-0.430.641.07
Upgrade
Stock-Based Compensation
1.043.335.435.574.48
Upgrade
Other Operating Activities
9.371.90.050.060.08
Upgrade
Change in Accounts Payable
17.27-1.33-1.651.82-1.32
Upgrade
Change in Other Net Operating Assets
1.09-1.34-2.7210.12-5.3
Upgrade
Operating Cash Flow
-6.73-18.62-36.91-42.93-52.31
Upgrade
Capital Expenditures
----0.2-0.22
Upgrade
Sale of Property, Plant & Equipment
--0.08--
Upgrade
Cash Acquisitions
-17.37----
Upgrade
Investment in Securities
-11.6522.2512.58-47.83
Upgrade
Investing Cash Flow
-17.3711.6522.3312.38-48.05
Upgrade
Issuance of Common Stock
0.03-3.080.71-
Upgrade
Other Financing Activities
---0.2-0.2-
Upgrade
Financing Cash Flow
266.84-2.880.51-
Upgrade
Foreign Exchange Rate Adjustments
0.71-0.320.380.26-0.92
Upgrade
Net Cash Flow
243.45-7.29-11.32-29.78-101.27
Upgrade
Free Cash Flow
-6.73-18.62-36.91-43.13-52.53
Upgrade
Free Cash Flow Per Share
-4.93-16.09-34.73-42.43-51.99
Upgrade
Cash Income Tax Paid
0.01----
Upgrade
Levered Free Cash Flow
-3.05-10.55-21.45-19.68-33.19
Upgrade
Unlevered Free Cash Flow
-3.05-10.55-21.45-19.68-33.19
Upgrade
Change in Working Capital
18.36-2.67-4.3711.94-6.62
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.